Analyzing Surgery Partners (SGRY) & The Competition

Surgery Partners (NASDAQ: SGRY) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its rivals? We will compare Surgery Partners to similar companies based on the strength of its valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Institutional & Insider Ownership

94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Surgery Partners and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Surgery Partners $1.15 billion $9.45 million -19.24
Surgery Partners Competitors $1.06 billion -$22.56 million 752.94

Surgery Partners has higher revenue and earnings than its rivals. Surgery Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for Surgery Partners and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners 1 3 4 0 2.38
Surgery Partners Competitors 58 326 511 9 2.52

Surgery Partners presently has a consensus price target of $18.00, suggesting a potential upside of 103.39%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 20.43%. Given Surgery Partners’ higher probable upside, analysts plainly believe Surgery Partners is more favorable than its rivals.

Risk & Volatility

Surgery Partners has a beta of 1.89, meaning that its stock price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ rivals have a beta of 1.47, meaning that their average stock price is 47% more volatile than the S&P 500.

Profitability

This table compares Surgery Partners and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Surgery Partners -0.33% 1.03% 0.20%
Surgery Partners Competitors 3.52% 3.52% 4.31%

Summary

Surgery Partners rivals beat Surgery Partners on 8 of the 13 factors compared.

About Surgery Partners

Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.

Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply